Matthew 25 Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Matthew 25 Management's LLY Position: Q3 2026 in Review
Matthew 25 Management reduced its Eli Lilly (LLY) stake by 10% in Q3 2026, selling an estimated $2.95M and leaving 22,000 shares worth $25.5M. The position accounts for 7.38% of the portfolio, ranked #3.
Matthew 25 Management first reported a position in LLY in Q2 2025 and has held it in 6 quarters since. The position peaked at $29.4M in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Matthew 25 Management held 22,000 shares of Eli Lilly worth $25.5M as of Q3 2026.
- Matthew 25 Management sold 2,500 Eli Lilly shares in Q3 2026, an estimated $2.95M.
- Eli Lilly made up 7.38% of Matthew 25 Management's portfolio in Q3 2026, its #3 holding.
- Matthew 25 Management first reported a position in Eli Lilly in Q2 2025 and has held it in 6 quarters since.
- Matthew 25 Management's Eli Lilly position peaked at $29.4M in Q2 2026.
- 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Matthew 25 Management's 13F filing for Q3 2026, filed 10 Nov 2026.